Diabetes management system developer Diabeloop will use the funding from the Agir à dom and Air Liquide-backed round to accelerate growth.

France-based medical device developer Diabeloop completed a €31m ($34.1m) series B round yesterday featuring home healthcare provider Agir à dom and Aliad, the investment arm of industrial gases supplier Air Liquide. The €22m equity portion of the round was led by family office Cemag Invest and included financial services firm Crédit Agricole, which participated through…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.